Small bowel transplantation poses two major problems. Firstly, transplanting the small bowel between two unrelated individuals results in two different immunological reactions: host versus graft reaction (graft rejection) and graft versus host reaction. The large amount of transplanted lymphoid tissue is responsible for this highly immunogenic character of an intestinal allograft. Secondly, the surgical procedure of small bowel transplantation inevitably involves transection of the intestinal wall with intrinsic and extrinsic denervation, interruption of lymphatic drainage, and preservationinduced injury. Sarr.67 The exact role of denervation on gastrointestinal hormone concentrations has not yet been elucidated, but adaptive changes in the neuropeptides of the gut may alter the enteric physiology after transplantation. The influence of neuropeptides in modulating the gastrointestinal neuroimmune axis would be of interest since it has been shown that VIP exerts potent immunosuppressive actions via T cell-specific mechanisms, which may play a role after transplantation. 14 
Immune function
The small bowel contains a large accumulation of lymphoid tissue in mesenteric lymph nodes, Peyer's patches, lamina propria, and epithelium. Little is known Leading articles express the views of the author and not those of the editor and the editorial board.
Functional aspects of small bowel transplantation: past, present, andffuture of the immune function of the transplanted small bowel, although it is obvious that long term survival with a graft necessitates a well functioning local immune system. 15 In an effort to understand the immune function of transplanted small bowel, Xia and Kirkman reported a consecutive series of studies about specific secretory immunoglobulin A (sIgA) production against cholera toxin in a rat small bowel transplantation model. [16] [17] [18] [19] [20] They found no difference in total sIgA production after syngeneic or allogeneic small bowel transplantation, but noted that allografts are less effective in producing a primary sIgA response against cholera toxin than isografts.'6 After priming the donor, however, small bowel allografts are capable of producing a secondary sIgA response to a booster of cholera toxin seven days after transplantation.'7 Cyclosporin A treatment has no effect on total sIgA production, but it suppresses the sIgA response to cholera toxin in both allografts and isografts.'8 This inhibitory effect of cyclosporin A lasts as long as the recipients are receiving it. In another experiment the authors showed that cyclosporin A only inhibits sIgA production against a T cell dependent antigen such as cholera toxin, but not against a T cell independent antigen (tinitrophenyl-lipopoly saccharide). 19 Xia suggested that this unresponsiveness against T cell dependent antigen cyclosporin A treated recipients explains the high incidence of septic complications after small bowel transplantation. Recently 34 35 Kimura showed that pigs transplanted with a segmental jejunal allograft (25% of total small bowel length) increased their body weight by almost 40% after six months, whereas all enterectomised control pigs suffered from malnutrition with progressive weight loss. 36 Kimura concluded that porcine segmental small bowel allografts maintain their compensatory capacity and hypertrophy after massive small bowel reduction. Recently, we showed that dogs with a major histocompatibility complex (MHC) matched, orthotopic segmental graft, comprising 25 to 30% of total small bowel length, regained their preoperative body weight after 20 weeks. 37 We are now performing orthotopic segmental small bowel transplants in immature dogs, which show a near normal weight gain (unpublished data).
NUTRIENT ABSORPTION
With regard to clinical small bowel transplantation, absorptive function of the transplanted bowel is the most important physiological determinant of graft function. It is likely that absorptive function after transplantation will be altered -at least temporarily -because of harvest injury, extrinsic denervation, transection of intrinsic neural continuity, and disruption of lymphatics. At present, however, intestinal absorptive function after transplantation is not fully understood and inconsistent studies have been reported. The different results may be explained by the varied experimental protocols. In addition, differences may be related to either the transplantation procedure itself or the immunological phenomena that follow.
Nutrient absorption studies after transplantation in rats showed prolonged malabsorption of fat and fat soluble vitamins (A and E), reduced uptake of glucose and glycine, and reduced glucose stimulated electrophysiological parameters.2' 23 38 Other rat studies showed normal faecal fat excretion, normal glucose and vitamin B-12 uptake, and relatively normal electrophysiological characteristics in non-rejecting small bowel grafts.2' 22 early fat absorption may be the opening of lymphovenous communications in the mesentery if the lymphatic drainage is obstructed48 as a pathway for absorption of fat until the regenerated lymphatics take over. Impaired intestinal absorption of fat has been reported by Thompson in canine small bowel autotransplants more than 12 months after transplantation, probably because of bacterial overgrowth in the transplanted jejunum and ileum. 29 Adequate cyclosporin A absorption in the small bowel is vital for a recipient with an allograft.22 44 49 Cyclosporin A is a lipophilic agent and is absorbed through the lymphatic drainage. Schraut suggested that cyclosporin A absorption in the early period after transplant may be compromised because of disrupted lymphatics.50 This has been underlined by investigators who found a low incidence of small bowel graft rejection if cyclosporin A was administered parenterally in the peritransplant period.34 35 Other investigators found normal cyclosporin A absorption after oral or intraluminal treatment, even in the first week after transplant.22 51 52 Cohen explained this by cyclosporin A absorption via the peritoneal membrane.53 According to Cohen, cyclosporin A leaks into the peritoneal cavity through the disrupted lymphatics, after which it is absorbed. It may be that cyclosporin A is absorbed via lymphovenous anastomoses in the mesentery. However, during the early period after transplant it seems justified to treat the recipient with parenteral cyclosporin A, because plasma concentrations may be unpredictable during this time and rejection episodes will impair the absorptive capacity for cyclosporin A.49 54 Complicating factors may be that cyclosporin A itself reduces nutrient absorption and adversely affects the microvasculature of the small bowel.55 56 WATER AND ELECTROLYTE ABSORPTION Several studies in rats have shown that net absorption of electrolyte solutions is decreased early after small bowel transplantation.37 57 Extrinsic denervation may be the underlying cause, since denervated small bowel secretes water and chloride from the crypts as a consequence of loss of sympathetic input.58 59 Using electrophysiological measurements we found indirect evidence that extrinsic denervation leads to increased secretory activity of the crypts in a heterotopic autotransplant model in dogs.60 It has been suggested that extrinsic denervation after small bowel transplantation plays a much more important part in the fluid and electrolyte balance than in the absorption of nutrients. Watson found that glucose can reverse the secretory state found with isotonic saline, which implies that glucose electrolyte solutions may be clinically useful in promoting electrolyte absorption after transplantation. 37 Sigalet observed an increase in sodium/glucose cotransporter activity after small bowel transplantation, which may be compensatory and restore the electrolyte balance.23 However, a recent canine study found no significant effect on jejunal absorption using a balanced physiological saline solution before or after transplant.6' At present, it is uncertain whether regeneration of extrinsic neural continuity or adaptation to chronic denervation takes place.
Barrier fimction Impaired gut barrier function is a possible aetiological factor in the development of multiorgan failure.62 The high incidence of infectious complications and sepsis after small bowel transplantation may be a result of excessive immunosuppression, but a compromised barrier function of native or grafted small bowel may also be important. We evaluated the mucosal integrity of acute rejecting intestinal grafts by analysing albumin contents in the graft effluent and found a protein losing enteropathy corresponding with rejection, which suggests that the mucosa barrier is highly permeable during a rejection episode. 63 In a study in rats Grant showed that rejection of orthotopic small bowel grafts leads to increased intestinal permeability to 51Cr-EDTA and increased bacterial translocation from the lumen of the graft to the host's mesenteric lymph nodes, liver, and spleen.64 He proposed that bacterial translocation may stimulate immune responses, which contributes to the intensity and rapidity of small bowel graft rejection. In a heterotopic rat model, Fabian reported increased bacterial translocation not only in small bowel allografts, but also in isografts, suggesting that the transplantation process itself affects the intestinal permeability independently of rejection. 65 Browne showed that the transplantation procedure itself leads to Gram negative aerobic overgrowth within the transplanted small bowel segment and ascending colon.66 Significant translocation of bacteria to the mesenteric lymph nodes occurred only when cyclosporin A was added. Remarkably, Gram negative organisms were more commonly isolated from the native mesenteric lymph nodes that from the graft, which suggests translocation through both native and transplanted small bowel.66 Cyclosporin A facilitates distant dissemination to liver, spleen, and lung once translocation has occurred. Therefore, both bacterial overgrowth and immunosuppression are associated with translocation and sepsis after small bowel transplantation.
Future directions Future research should be directed to a better understanding and prevention of acute and chronic rejection. The induction of specific tolerance or improved immunosuppressive agents may be a prerequisite for the success of clinical transplantation. MHC matching may be valuable in reducing the vigorous immunosuppressive regimen.37 In addition, MHC matching may pave the way for livingrelated intestinal transplantation.
New approaches to prevent infectious complications and to enhance the mucosal barrier should be considered. In this context selective gut decontamination, early enteral feeding, and modified total parenteral nutrition may be important tools. Potential beneficial effects of glutamine, short chain fatty acids, and polyamines added to enteral or parenteral nutrition should be investigated. [67] [68] [69] [70] The possible protecting effect of a liver graft in conjunction with a small bowel graft is an important issue. [71] [72] [73] Although experimental studies and one clinical case showed the superiority of combined small bowel liver transplantation, this benefit could not be confirmed in the first reported series of intestinal transplantation either in composite visceral grafts or alone. 
